Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin with or without physiotherapy for diabetic peripheral neuropathy
IRCT20241221064123N1Phase 4Completed
- Sponsor
- Zabol University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gabapentin in diabetic polyneuropathy (DPN) (5 arms), sponsored by Zabol University of Medical Sciences. Primary endpoint: Reducing symptoms of diabetic neuropathy. Started Aug 2025; status: completed.
02
Drugs
gabapentin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20241221064123N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241221064123N1.